Does Wegovy cause acid reflux, and what can you do about it?

Why does Wegovy seem to trigger acid reflux in some people?

Semaglutide, the active ingredient in Wegovy, is a GLP-1 receptor agonist. One of its core actions is slowing gastric emptying, food leaves the stomach more gradually, which is part of how the medicine reduces appetite and calorie intake. The trade-off is that acid can pool in the stomach for longer than usual, and if some of it creeps back into the oesophagus, the result is the familiar burning sensation of reflux.

This is not a quirk specific to Wegovy; it is a property of GLP-1 medicines as a class. The NHS medicines page for semaglutide lists indigestion and burping among the common side effects, alongside nausea, which many people find is the more prominent companion in early treatment. If you are already curious about the broader GI picture, our guide to Wegovy's side effects covers the full range.

The timing matters too. Reflux on Wegovy often tracks the dose schedule: a bump in symptoms when the pen first starts, another when the dose increases, and then a gradual settling as the body adjusts. If you are wondering whether Wegovy can give you acid reflux and why some people are more susceptible than others, that pattern is worth keeping in mind if you are currently in the middle of an uncomfortable first few weeks.

Can the way you eat or sleep make acid reflux on Wegovy worse?

Almost certainly, yes. Because gastric emptying is already slowed, certain habits that are ordinarily manageable can tip into discomfort more easily. Large meals fill a stomach that is already working more slowly; fatty or spicy foods stimulate extra acid secretion; lying down shortly after eating gives that acid an easy route upward. Caffeine and alcohol both relax the lower oesophageal sphincter, the valve that is supposed to keep stomach contents where they belong.

Practical adjustments that tend to help: smaller portions spread across the day rather than two or three large meals; leaving two to three hours between eating and lying down; sleeping with the head of the bed slightly elevated if night-time symptoms are a problem; and avoiding the trigger foods that you know already bother you. None of these replace clinical guidance, but our detailed guide to managing acid reflux while taking Wegovy explains how many people find they significantly reduce the frequency and intensity of symptoms.

There is a separate, related experience that catches people off guard: the sudden burping (sometimes with a sour taste) that can follow even small amounts of food. Our page on Wegovy acid burps explains why this happens and how it differs from classic reflux.

When should acid reflux on Wegovy prompt a call to your prescriber?

Mild heartburn that comes and goes is very different from the kind of pain that needs urgent attention. The MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as a known (if infrequent) serious side effect of GLP-1 medicines. The key symptom to watch for is severe, persistent stomach pain that radiates toward the back, sometimes accompanied by vomiting. That is not typical reflux; it needs same-day medical review.

Separately, if your reflux is bad enough to affect sleep, is getting worse rather than better after the first few weeks, or is accompanied by difficulty swallowing, unintended weight loss beyond what you expected, or blood in vomit, contact a clinician promptly. You can also report any suspected side effects directly through the MHRA's Yellow Card scheme.

For reflux that is uncomfortable but not alarming, your prescriber may consider slowing the titration pace (staying on a lower dose for longer before stepping up) which often brings GI side effects down to a manageable level. That is a conversation worth having rather than stopping treatment abruptly. Our page on how long Wegovy side effects last gives more context on what the typical timeline looks like.

Does acid reflux mean Wegovy is not right for you?

Not necessarily. Reflux during the early weeks of treatment is common enough that prescribers expect it and plan for it. The question is whether it stays within a range you can manage and that is not causing harm, versus whether it is a sign of an underlying condition (for instance, a hiatus hernia or pre-existing gastro-oesophageal reflux disease) that warrants a different approach.

People with a history of significant oesophageal or stomach conditions will have those discussed during a clinical assessment before starting. If your symptoms develop or worsen after treatment begins, that is equally important to disclose. Suitability is never assessed on BMI alone; the full clinical picture shapes the prescriber's decision.

If you are wondering whether you are a candidate for Wegovy or whether your reflux history is a barrier, a prescriber is the right person to ask. At nume, our clinician-led service puts your consultation in front of a GPhC-registered prescriber (a real clinician, not an automated system) on the day you submit it. If you would like to understand the cost side of treatment before you begin, our Wegovy price comparison page sets out what the UK private market looks like and what an all-inclusive price actually covers. When you are ready, you can check your eligibility and start a free consultation with no obligation.